Characteristic | Total | Synchronous group (n = 22) | Metachronous group (n = 46) | Pvalue * |
---|---|---|---|---|
Age (years) † | ||||
< 58 b | 33 | 8 | 25 | 0.165 |
≥ 58 | 35 | 14 | 21 | |
Gender | 0.514 | |||
Male | 61 | 21 | 40 | |
Female | 7 | 1 | 6 | |
HBsAg status | 0.393 | |||
Negative | 23 | 9 | 14 | |
Positive | 45 | 13 | 32 | |
Serum AFP level (ng/ml) | 0.085 | |||
< 25 | 30 | 13 | 17 | |
≥ 25 | 38 | 9 | 29 | |
Serum GGT level (U/ml) | 0.181 | |||
< 50 | 23 | 5 | 18 | |
≥ 50 | 45 | 17 | 28 | |
Child-Pugh classification | 0.932 | |||
A | 49 | 16 | 33 | |
B | 19 | 6 | 13 | |
TNM stage | 0.735 | |||
I | 43 | 14 | 29 | |
II | 9 | 2 | 7 | |
III | 16 | 6 | 10 | |
Treatment for HCC | 0.309 | |||
Resection | 35 | 9 | 26 | |
Ablation | 7 | 3 | 4 | |
TACE | 14 | 4 | 10 | |
Supportive | 11 | 6 | 5 | |
Treatment for extrahepatic cancer | <0.001 | |||
Curative | 54 | 12 | 42 | |
Palliative | 8 | 4 | 4 | |
Supportive | 6 | 6 | 0 |